Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BYBiomedicines

Comparative Prognostic Value of AFP, PIVKA-II, and GPC-3 in Hepatocellular Carcinoma: A Real-World Multicenter Cohort Study

  • Francesco Damone1
  • Gian Paolo Caviglia2
  • Piero Colombatto1
  • Filippo Oliveri1
  • Marta Guariglia2
  • Gabriele Ricco1
  • Veronica Romagnoli1
  • Daniela Cavallone1
  • Emanuela Rolle3
  • Patrizia Carucci3
  • Francesco Faita4
  • Ferruccio Bonino4
2 more authors
  • Silvia Gaia3
  • Maurizia Rossana Brunetto1
4 affiliations
  1. 1Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, 56124 Pisa, Italy; (F.D.); (P.C.); (F.O.); (G.R.); (V.R.); (D.C.)
  2. 2Department of Medical Sciences, University of Turin, 10126 Turin, Italy; (G.P.C.); (M.G.)
  3. 3Gastroenterology Unit, Città della Salute e della Scienza—Molinette Hospital, 10126 Turin, Italy; (E.R.); (P.C.); (S.G.)
  4. 4Institute of Clinical Physiology, Italian National Research Council (IFC-CNR), Via Moruzzi, 1 56124 Pisa, Italy; (F.F.); (F.B.)
Read full textPDFCite

Related

  1. Prognostic Significance of Response Dynamics in Atezolizumab plus Bevacizumab-Treated Hepatocellular Carcinoma: A Multicenter Real-World Validation Study.
    Renguo Guan, Kaijun Huang, Zehao Zheng +5
    Liver cancerPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study.
    Takuya Sho, Goki Suda, Tamami Abe +28
    Liver cancerPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study.
    Jian Zheng, Wenbin Shen, Jianzhong Cao +13
    MedCommPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study
    Monica Tincopa, Lana Bridi, Irine Vodkin +11
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCEurope PMC
  5. Prognostic Modeling of 1-Year Survival in Hepatocellular Carcinoma: A Comparative Evaluation of Machine Learning Methods with Class Balancing.
    Jinlian Wang, Hui Li, Changqing Ju +1
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{damone2026comparative,
  title = {{Comparative Prognostic Value of AFP, PIVKA-II, and GPC-3 in Hepatocellular Carcinoma: A Real-World Multicenter Cohort Study}},
  author = {Francesco Damone and Gian Paolo Caviglia and Piero Colombatto and Filippo Oliveri and Marta Guariglia and Gabriele Ricco and Veronica Romagnoli and Daniela Cavallone and Emanuela Rolle and Patrizia Carucci and Francesco Faita and Ferruccio Bonino and Silvia Gaia and Maurizia Rossana Brunetto},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701469},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Comparative Prognostic Value of AFP, PIVKA-II, and GPC-3 in Hepatocellular Carcinoma: A Real-World Multicenter Cohort Study
AU  - Francesco Damone
AU  - Gian Paolo Caviglia
AU  - Piero Colombatto
AU  - Filippo Oliveri
AU  - Marta Guariglia
AU  - Gabriele Ricco
AU  - Veronica Romagnoli
AU  - Daniela Cavallone
AU  - Emanuela Rolle
AU  - Patrizia Carucci
AU  - Francesco Faita
AU  - Ferruccio Bonino
AU  - Silvia Gaia
AU  - Maurizia Rossana Brunetto
PY  - 2026
DA  - 2026/09/23
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701469
SN  - 2227-9059
ER  -